Home › Therapeutic areas › Neurology › Generalized Anxiety Disorder
Generalized Anxiety Disorder (5 companies)
Companies with an active program in Generalized Anxiety Disorder.
| Ticker | Company | Therapeutic areas | Programs | Lead stage | Programs |
|---|---|---|---|---|---|
| ATAI | AtaiBeckley Inc. | Neurology | 1 | Phase 3 | 5 |
| HELP | CYBIN INC. | Neurology | 1 | Phase 2 | 4 |
| DFTX | Definium Therapeutics, Inc. | Neurology | 1 | Phase 3 | 4 |
| IXHL | Incannex Healthcare Inc. | ImmunologyNeurologyRespiratory | 1 | Phase 2 | 3 |
| VNDA | Vanda Pharmaceuticals Inc. | CardiovascularDermatologyGI/HepatologyHematologyImmunologyInfectious DiseaseNeurologyOphthalmology Rare | 1 | Approved | 26 |
No companies match.